Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Terplex gene delivery system.

Sung Wan Kim1

  • 1Department of Pharmaceutics and Pharmaceutical Chemistry University of Utah, Salt Lake City, Utah 84112, USA.

Advances in Genetics
|October 26, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Resilience practices of healthcare professionals during the hospital discharge process: a qualitative study.

International journal for quality in health care : journal of the International Society for Quality in Health Care·2026
Same author

A Case of Primary Tuberculosis of the Paranasal Sinuses.

Journal of rhinology : official journal of the Korean Rhinologic Society·2024
Same author

The Effect of Multilevel Surgery for Obstructive Sleep Apnea on Fatigue, Stress and Resilience.

Journal of clinical medicine·2023
Same author

Interaction effects between insomnia and depression on risk of out-of-hospital cardiac arrest: Multi-center study.

PloS one·2023
Same author

Reduced Coronary Flow Reserve Is Associated with Impaired Ventricular-vascular Interaction in Patients with Obstructive Sleep Apnea.

International journal of heart failure·2022
Same author

Pneumatized Inferior Turbinate: A Report of Three Cases.

Cureus·2022
Same journal

Shaping mammalian genomes: The regulation and co-option of transposable elements in early development and gametogenesis.

Advances in genetics·2026
Same journal

Transposable elements in aging: From biomarkers to effectors.

Advances in genetics·2026
Same journal

Transposable elements in human cancer: Regulation, activation, and genomic consequences.

Advances in genetics·2026
Same journal

Retrotransposons as both "architects" and "saboteurs" in the nervous system.

Advances in genetics·2026
Same journal

Transposable element analysis in OMICS data.

Advances in genetics·2026
Same journal

The implication of lncRNAs in the regulation of inflammation.

Advances in genetics·2026
See all related articles

A novel Terplex gene delivery system offers a non-viral, low-cytotoxic alternative for gene therapy. This stable, charge-balanced system enhances cellular uptake and vascular retention for effective gene delivery, such as with the VEGF gene.

Area of Science:

  • Biotechnology
  • Gene Therapy
  • Nanomedicine

Background:

  • Viral vectors for gene delivery pose challenges like cytotoxicity and limited size capacity.
  • Non-viral polymeric gene delivery systems offer advantages including low cytotoxicity, scalability, cost-effectiveness, and reproducibility.
  • Developing efficient and safe non-viral vectors is crucial for advancing in vivo gene therapy.

Purpose of the Study:

  • To design and characterize a novel Terplex gene delivery system.
  • To evaluate the stability, size, and cellular uptake efficiency of the Terplex system.
  • To assess the in vivo performance of the Terplex system for gene augmentation in myocardial infarction.

Main Methods:

  • Formulation of plasmid DNA with low-density lipoprotein (LDL) and hydrophobized poly-L-lysine (PLL) to create the Terplex system.

Related Experiment Videos

  • Characterization of the Terplex complex for stability, hydrophobicity/charge balance, and size.
  • Assessment of DNA integrity post-complexation.
  • Evaluation of vascular retention time compared to naked DNA.
  • Application of the Terplex system for VEGF gene delivery to myocardial infarction sites.

    • Main Results:

    • A stable, hydrophobicity/charge-balanced Terplex system of optimal size for cellular uptake was successfully developed.
    • Plasmid DNA integrity was maintained after formulation into the Terplex complex.
    • The Terplex DNA complex demonstrated significantly longer retention in the vascular space compared to naked DNA.
    • The Terplex system facilitated myocardial transfection at an infarction site using the VEGF gene.

    Conclusions:

    • The Terplex gene delivery system represents a promising non-viral vector with enhanced cellular uptake and vascular retention.
    • The system's stability and ability to protect DNA integrity make it suitable for in vivo gene therapy applications.
    • Further development of this Terplex system could lead to improved transfection efficiency for therapeutic gene delivery, particularly in cardiovascular applications.